and the REWIND trial (NCT01394952), which looked at dulaglutide (Trulicity
They can be used in the short or long term and rarely interact with other medications
Farngren J, Ahrn B (2019) Incretin-based medications (GLP-1 receptor agonists, DPP-4 inhibitors) as a means to avoid hypoglycaemic episodes
This catalog specification provides 50mg per vial in lyophilized powder format
If you experience significant injection pain, bruising, or nodules despite proper rotation, contact your PlexusDx care team to discuss alternative formulations or injection techniques
However, after GLP-1RAs treatment, the joint structural damage was significantly alleviated and osteophyte formation was reduced (Fig